Sign up for our daily briefing

Make your busy days simpler with Axios AM/PM. Catch up on what's new and why it matters in just 5 minutes.

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Catch up on the day's biggest business stories

Subscribe to Axios Closer for insights into the day’s business news and trends and why they matter

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Sign up for Axios Pro Rata

Dive into the world of dealmakers across VC, PE and M&A with Axios Pro Rata. Delivered daily to your inbox by Dan Primack and Kia Kokalitcheva.

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Sports news worthy of your time

Binge on the stats and stories that drive the sports world with Axios Sports. Sign up for free.

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Tech news worthy of your time

Get our smart take on technology from the Valley and D.C. with Axios Login. Sign up for free.

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Get the inside stories

Get an insider's guide to the new White House with Axios Sneak Peek. Sign up for free.

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Catch up on coronavirus stories and special reports, curated by Mike Allen everyday

Catch up on coronavirus stories and special reports, curated by Mike Allen everyday

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Want a daily digest of the top Denver news?

Get a daily digest of the most important stories affecting your hometown with Axios Denver

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Want a daily digest of the top Des Moines news?

Get a daily digest of the most important stories affecting your hometown with Axios Des Moines

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Want a daily digest of the top Twin Cities news?

Get a daily digest of the most important stories affecting your hometown with Axios Twin Cities

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Want a daily digest of the top Tampa Bay news?

Get a daily digest of the most important stories affecting your hometown with Axios Tampa Bay

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Want a daily digest of the top Charlotte news?

Get a daily digest of the most important stories affecting your hometown with Axios Charlotte

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Want a daily digest of the top Nashville news?

Get a daily digest of the most important stories affecting your hometown with the Axios Nashville newsletter.

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Want a daily digest of the top Columbus news?

Get a daily digest of the most important stories affecting your hometown with the Axios Columbus newsletter.

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Want a daily digest of the top Dallas news?

Get a daily digest of the most important stories affecting your hometown with the Axios Dallas newsletter.

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Want a daily digest of the top Austin news?

Get a daily digest of the most important stories affecting your hometown with the Axios Austin newsletter.

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Want a daily digest of the top Atlanta news?

Get a daily digest of the most important stories affecting your hometown with the Axios Atlanta newsletter.

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Want a daily digest of the top Philadelphia news?

Get a daily digest of the most important stories affecting your hometown with the Axios Philadelphia newsletter.

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Want a daily digest of the top Chicago news?

Get a daily digest of the most important stories affecting your hometown with the Axios Chicago newsletter.

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Sign up for Axios NW Arkansas

Stay up-to-date on the most important and interesting stories affecting NW Arkansas, authored by local reporters

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Want a daily digest of the top DC news?

Get a daily digest of the most important stories affecting your hometown with the Axios DC newsletter.

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Illustration: Sarah Grillo/Axios

Companies that make products geared toward staying at home — think peanut butter, exercise bikes and telecommunication software — are the unexpected beneficiaries of the evolving coronavirus economy.

Why it matters: There are dour forecasts for the global economy as the coronavirus runs its course. But investors are placing bets on what consumers will need as the fast-spreading outbreak worsens.

Where things stand: While last week's coronavirus sell-off in the markets left few companies unscathed and this week's rebound has been a big help, there are some companies whose stock movements — up or down stand out:

  • Only 7 out of 500 publicly traded companies in the U.S. gained value last week, according to the Wall Street Journal — including Clorox, the disinfectant manufacturer, and Gilead Sciences and Regeneron, which are working on coronavirus treatments.

Other noteworthy stock gainers throughout the stock market's jittery run include other pharma companies — like Moderna, whose vaccine is in the midst of an early clinical trial — and tech companies that connect people when movement around the globe is limited, like Zoom, Teledoc and Dropbox.

  • Peloton, whose home exercise bikes save people trips to germ-laden gyms, briefly saw its shares spike amid the broader market's sell-off.

Conversely, travel companies — like the major cruise lines, plus big airlines and hotel chains — have been punished. American Airlines, which flies lots of Pacific routes, lost 25% of its value over four trading days, Forbes noted.

There's been a clear trend favoring companies that could benefit from people staying home, filling their pantries and preparing for a worsening outbreak.

  • B&G Foods, which makes long-lasting pantry goods including B&M canned beans and Cream of Wheat, has caught relative favor with investors, as has comfort food producer J.M. Smucker, which makes peanut butter and jelly.
  • Clorox's bleach and disinfectant wipes are being piled into shopping carts across the country.

Purell hand sanitizers and wipes are flying off store shelves so quickly that consumers complain they can't get hold of them. The maker of Purell — privately held Gojo Industries — tells Axios that it has increased production.

  • Supply of hand sanitizers and medical face masks — which consumers are also stocking up on, despite warnings from medical professionals — "have already dried up in some markets, with no clear indication of when supplies will be replenished," according to a new report by Nielsen.

The big picture: Even as market pressures eased, investors crowded into names that could see increased demand amid coronavirus fears.

  • On Monday, the S&P 500 jumped 4% and Costco was the best-performing stock in the index, rising 10%.
  • "As consumers prioritize a dwindling number of trips to stores, Costco will likely be at the top of the list," Michael Lasser, an analyst at UBS, wrote in a note to clients this week.
  • Products like toilet paper, frozen food and bottled water are inspiring "panic buying" and stockpiling, the Washington Post reported.

Supermarkets and other suppliers of basic goods are hunkering down and preparing for increased traffic to their stores.

  • What they're saying: "Instead of one eight-hour shift, retailers are adding a second or third shift to do 24-hour around-the-clock deliveries to get products people need for maximum safety," Burt Flickinger, who runs Strategic Resource Group and is a longtime consultant to the retail industry, tells Axios.

Go deeper:

Go deeper

Updated 58 mins ago - Health

First North American Omicron cases identified in Canada

COVID-19 testing personnel at Toronto Pearson International Airport in September. Photo: Steve Russell/Toronto Star via Getty Images

The first two cases of the new Omicron variant have been detected in North America, the Canadian government announced Sunday evening.

Driving the news: The World Health Organization has named Omicron a "variant of concern," but cautioned earlier on Sunday that it is not yet clear whether it's more transmissible than other strains of COVID-19.

Former Defense Secretary Esper sues Pentagon over book

Former President Trump and former Defense Secretary Mark Esper at the White House in 2020. Photo: Mandel Ngan/AFP via Getty Images

Former Defense Secretary Mark Esper filed a lawsuit Sunday against the Defense Department, accusing the Pentagon of "censoring" his First Amendment rights by redacting parts of his upcoming book on the Trump administration.

The big picture: Esper, who served as defense secretary from July 2019 until he was fired by then-President Trump in November last year, alleges in the suit that "significant text" is "being improperly withheld from publication" of the manuscript "under the guise of classification."

WHO warns against travel bans on southern African countries

Matshidiso Moeti, World Health Organization regional director for Africa. Photo: Sylvain Gaboury/Patrick McMullan via Getty Images

The World Health Organization called on countries Sunday to not impose travel bans on southern African nations amid concerns over the new COVID-19 Omicron variant.

Why it matters: The U.S. and countries in Europe and the Asia-Pacific announced travel restrictions in response to Omicron, which was first detected in South Africa. It's since spread to several European countries, Canada, Israel, Australia and Hong Kong. The WHO noted in a statement that only two southern African nations have detected the new variant.